carbostyril has been researched along with Bronchitis in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.23) | 18.7374 |
| 1990's | 25 (80.65) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 2 (6.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, M; Liu, P; Wang, J; Xu, H | 1 |
| Adriaenssens, N; Bartholomeeusen, S; Coenen, S; Ryckebosch, P | 1 |
| Dimopoulos, G; Falagas, ME; Korbila, IP; Manta, K; Siempos, II | 1 |
| Cesana, M; Focht, J; Klietmann, W; Rondel, RK | 1 |
| Breisch, S; Chodosh, S; Lakshminarayan, S; Swarz, H | 1 |
| Amantea, MA; Chodosh, S; Collins, DA; Forrest, A; Schentag, JJ | 1 |
| Breisch, S; Cranfield, R; Langan, CE; Pettit, R | 1 |
| Chuck, SK; Jung, R; Martin, SJ; Messick, CR; Meyer, JM; Pendland, SL | 1 |
| Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D | 1 |
| Friis, HM | 1 |
| Bykova, AV; Emel'ianov, AV; Fedoseev, GB; Rudinskiĭ, KA; Shevelev, SE | 1 |
| Iakovlev, SV | 1 |
| Dorr, MB; Lipsky, BA; Magner, DJ; Talbot, GH | 1 |
| Bagby, B; Bettis, R; Collins, JJ; DeAbate, CA; Fleming, H; Giguere, G; Munk, ZM; Munn, NJ; Riffer, E | 1 |
| Belousov, IuB; Efremenkova, OV; Sokolov, AV; Tishenkova, IF | 1 |
| Cantoni, V; Melani, AS; Pirrelli, M; Sarlo, F | 1 |
| Dionisio, P; Grassi, C; Rosignoli, MT; Salvatori, E | 1 |
| Albera, C; Grassi, C; Pozzi, E | 1 |
| Ellison, WT; Gotfried, MH | 1 |
| Bruce-Jones, P; Crome, P | 1 |
| Rizk, E | 1 |
| Kemper, P; Köhler, D | 1 |
| Chodosh, S | 1 |
| Kosmidis, J | 1 |
| Chung, KF | 1 |
| Cremers, HM; Davies, BI; Gubbelmans, HL; Maesen, FP | 1 |
| Magnussen, H | 1 |
| Williams, HN | 1 |
8 review(s) available for carbostyril and Bronchitis
| Article | Year |
|---|---|
Network meta-analysis of success rate and safety in antibiotic treatments of bronchitis.
Topics: Anti-Bacterial Agents; Bronchitis; Cluster Analysis; Diarrhea; Gastrointestinal Microbiome; Humans; Intestines; Odds Ratio; Patient Safety; Quinolones; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bronchitis; Bronchitis, Chronic; Clavulanic Acid; Clinical Trials as Topic; Humans; Macrolides; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Treatment Outcome | 2007 |
Levofloxacin and sparfloxacin: new quinolone antibiotics.
Topics: Absorption; Anti-Infective Agents; Bronchitis; Drug Interactions; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia; Quinolones; Sinusitis; Skin Diseases; Urinary Tract Infections | 1998 |
Infection in the elderly: studies with lomefloxacin.
Topics: Aged; Aging; Anti-Infective Agents; Bacterial Infections; Bronchitis; Female; Fluoroquinolones; Humans; Male; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Premedication; Quinolones; Randomized Controlled Trials as Topic; Urinary Tract Infections | 1992 |
The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
Topics: Anti-Infective Agents; Bacterial Infections; Bronchitis; Fluoroquinolones; Humans; Meta-Analysis as Topic; Premedication; Quinolones; Randomized Controlled Trials as Topic; United States; Urinary Tract Infections | 1992 |
Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Fluoroquinolones; Humans; Ofloxacin; Quinolones | 1991 |
Pharmacology of airway inflammation in asthma.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Airway Resistance; Anti-Inflammatory Agents; Asthma; Bronchitis; Bronchodilator Agents; Cromolyn Sodium; Humans; Muscle, Smooth; Nedocromil; Quinolones; Theophylline | 1990 |
[Hypersensitivity of the respiratory tract: determination, occurrence and clinical significance].
Topics: Adrenal Cortex Hormones; Allergens; Asthma; Bronchitis; Chronic Disease; Humans; Ketotifen; Nedocromil; Quinolones; Respiratory Hypersensitivity | 1990 |
16 trial(s) available for carbostyril and Bronchitis
| Article | Year |
|---|---|
Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amoxicillin; Anti-Infective Agents; Bacteria; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Quinolones; Sputum | 1993 |
Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Bronchodilator Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Theophylline; Treatment Outcome | 1998 |
Pharmacokinetics and pharmacodynamics of oral grepafloxacin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Humans; Male; Middle Aged; Models, Biological; Piperazines; Quinolones; Time Factors | 1997 |
Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Hematologic Tests; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Piperazines; Quinolones; Treatment Outcome | 1997 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Cough; Double-Blind Method; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Haemophilus Infections; Haemophilus influenzae; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Ofloxacin; Placebos; Pneumococcal Infections; Quinolones; Sputum; Staphylococcal Infections; Treatment Outcome | 1998 |
[Efficacy of lomefloxacin in treatment of patients with chronic bronchitis].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chronic Disease; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moraxella catarrhalis; Neisseria; Quinolones; Roxithromycin; Sputum; Staphylococcus aureus; Streptococcus | 1998 |
[Pharmacodynamic and pharmacokinetic approaches to optimization of lomefloxacin].
Topics: Age Factors; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1998 |
Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Quinolones | 1999 |
[The importance of fluoroquinolones in treating pneumonia in the elderly].
Topics: Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Quinolones; Sputum; Time Factors | 1999 |
Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Dioxolanes; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Piperazines; Quinolones; Treatment Outcome | 2002 |
Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic Disease; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Quinolones; Recurrence; Treatment Outcome | 1992 |
Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefaclor; Chronic Disease; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Middle Aged; Quinolones; Recurrence; Single-Blind Method; Treatment Outcome | 1992 |
A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chi-Square Distribution; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Quinolones; Treatment Outcome | 1992 |
A double-blind study of once-daily temafloxacin in the treatment of bacterial lower respiratory tract infections.
Topics: Adolescent; Adult; Anti-Infective Agents; Bronchitis; Ciprofloxacin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Pneumonia; Quinolones; Respiratory Tract Infections | 1991 |
Temafloxacin in acute purulent exacerbations of chronic bronchitis.
Topics: 4-Quinolones; Anti-Infective Agents; Bronchitis; Chronic Disease; Drug Administration Schedule; Fluoroquinolones; Haemophilus influenzae; Humans; Moraxella catarrhalis; Pseudomonas aeruginosa; Quinolones; Sputum; Streptococcus pneumoniae | 1990 |
Multi-centre clinical trial of nedocromil sodium in reversible obstructive airways disease in adults: a general practitioner collaborative study.
Topics: Administration, Inhalation; Adult; Asthma; Bronchitis; Bronchodilator Agents; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nedocromil; Quinolones | 1989 |
7 other study(ies) available for carbostyril and Bronchitis
| Article | Year |
|---|---|
Quality of antibiotic prescription during office hours and out-of-hours in Flemish primary care, using European quality indicators.
Topics: Adolescent; Adult; After-Hours Care; Aged; Anti-Bacterial Agents; Bronchitis; Child; Child, Preschool; Cystitis; Databases, Factual; Drug Prescriptions; Female; Guideline Adherence; Humans; Infant; Middle Aged; Netherlands; Otitis Media; Pneumonia, Bacterial; Practice Guidelines as Topic; Primary Health Care; Quality Indicators, Health Care; Quinolones; Sinusitis; Tonsillitis; Young Adult | 2014 |
Breakpoint determination: rufloxacin.
Topics: Anti-Infective Agents; Bronchitis; Chronic Disease; Enterobacteriaceae; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Quinolones; Urinary Tract Infections | 1993 |
Sparfloxacin and levofloxacin.
Topics: Administration, Oral; Anti-Infective Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Drug Eruptions; Fluoroquinolones; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Photosensitivity Disorders; Pneumonia; Quinolones | 1997 |
New antibiotic approved for community-acquired infections.
Topics: Anti-Infective Agents; Bronchitis; Community-Acquired Infections; Contraindications; Fluoroquinolones; Humans; Piperazines; Pneumonia; Quinolones; Sexually Transmitted Diseases; United States; United States Food and Drug Administration | 1998 |
[Grepafloxacin (Raxar)].
Topics: Anti-Infective Agents; Bronchitis; Contraindications; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Piperazines; Pneumonia; Quinolones; Urethritis; Uterine Cervicitis | 1998 |
Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bronchitis; Clinical Trials, Phase III as Topic; Community-Acquired Infections; Data Interpretation, Statistical; Female; Fluoroquinolones; Heart Rate; Humans; Male; Middle Aged; Photosensitivity Disorders; Pneumonia, Bacterial; Quinolones; Sinusitis; Skin Diseases, Bacterial | 1999 |
Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents; Bronchitis; Cross-Sectional Studies; Female; Fluoroquinolones; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quinolones; Theophylline | 2001 |